Search

Search Results
Results 16971 - 16980 of 17225 for Active treatment
  • Relpax Migraine
    Drug - 25 May 2026
    Consumer Medicine Information (CMI) about Relpax Migraine intended for persons living in Australia.
  • Somac Heartburn Relief
    Drug - 22 May 2026
    Consumer Medicine Information (CMI) about Somac Heartburn Relief intended for persons living in Australia.
  • Xatral SR
    Drug - 21 May 2026
    Consumer Medicine Information (CMI) about Xatral SR intended for persons living in Australia.
  • Minims Tetracaine Hydrochloride
    Drug - 15 May 2026
    Consumer Medicine Information (CMI) about Minims Tetracaine Hydrochloride intended for persons living in Australia.
  • Apretude Injection
    Drug - 13 May 2026
    Consumer Medicine Information (CMI) about Apretude Injection intended for persons living in Australia.
  • Tripacel
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Tripacel intended for persons living in Australia.
  • Adacel Polio
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Adacel Polio intended for persons living in Australia.
  • Triasyn
    Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Triasyn intended for persons living in Australia.
  • Continuous monitoring in pharmaceutical cleanrooms
    White Paper - 6 May 2026
    Continuous monitoring ensures contamination control and GMP compliance in pharmaceutical cleanrooms, supporting sterility and consistent product quality.
  • Microbial sampling criteria in pharma
    White Paper - 30 Apr 2026
    Optimal microbial sampling approaches for pharmaceutical environments include surface, passive air, and active air monitoring methods.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback